mRNA Cancer Therapies Patent Landscape 2022
…the original documents, priority dates, titles, abstracts, patent assignees, each patent’s current legal status and segmentation. Companies mentioned in this report (non-exhaustive list) BioNTech, Cellectis, CoImmune, CureVac, eTheRNA immunotherapies, Factor Bioscience, Gritstone bio, ImmunityBio, Moderna, Myeloid Therapeutics, Novartis, RIKEN, Sanofi, Shanghai Telebio Biomedical, Tricision Biotechnology, Nutcracker Therapeutics, Orna Therapeutics, etc….